DOW Chemicals · Cyclical · Restructuring · Supply shock · Thesis updated June 13, 2026

Dow gets a shock-driven earnings bridge

Dow is a large, cyclical chemical maker, so its profit swings with prices, demand, and raw material costs.
Q1 2026 net sales were $9.8 billion, down 6% from Q1 2025 as local prices fell 7% and volume fell 2%.
Management guided Q2 2026 to about $12 billion of revenue and $2 billion of EBITDA, helped by Middle East supply disruption.
The Transform to Outperform plan targets at least $2 billion of near-term EBITDA improvement, but it also cuts about 4,500 roles.
The biggest debate is whether Dow is seeing a lasting earnings reset or a temporary price spike from a supply shock.

01 Running thesis

A tailwind meets a turnaround

Dow entered 2026 in a weak part of the chemical cycle. Prices were falling, demand was soft, and some markets had too much supply. Q1 2026 still showed that pain, with net sales down 6% year over year.

The story changed in March. Management said the conflict in the Middle East created a sharp positive inflection in orders and expects the supply disruption to last through 2026. It also said the disruption could take 275 days or longer to unwind. That gives Dow a chance to raise prices and run its cost-advantaged Americas assets harder.

The bull case is now two parts. First, tight supply could lift margins in polyethylene and related products. Second, Dow is cutting costs through Transform to Outperform, which targets at least $2 billion of near-term EBITDA improvement. If both happen together, Dow could earn much more than investors expected only a few months ago.

The bear case is just as direct. A supply shock can fade fast. If the Middle East disruption eases sooner than management expects, pricing could fall before the cost program is fully proven. The company is still cyclical, credit ratings were cut in February 2026, and the current valuation debate depends on earnings that have not yet been delivered.

Apr 2026→Dow's Q1 2026 10-Q confirmed weak year-over-year sales and price trends, but also supported management's view that Middle East supply disruption is helping near-term pricing. The filing added balance sheet risk, with S&P and Moody's credit rating downgrades in February 2026.

Apr 2026▲The Q1 2026 call changed the setup. Management guided Q2 to about $12 billion of revenue and $2 billion of EBITDA, helped by pricing gains, margin expansion, and a supply disruption it said could take 275 days or longer to unwind.

Feb 2026▼The 2025 10-K showed a weak year, with net sales of $40.0 billion, down 7% from 2024. It also made Transform to Outperform the center of the thesis, adding both a major cost-cut opportunity and a major execution risk.

Jan 2026→Dow announced Transform to Outperform, targeting at least $2 billion of near-term EBITDA improvement and a workforce reduction of about 4,500 roles. The plan improved the self-help case, but Q4 EBITDA of $741 million and weak Q1 guidance kept the cycle risk front and center.

Oct 2025→The Q3 2025 10-Q kept the prior view in place. Dow still faced slower global GDP growth, industry overcapacity, and pressure on results.

Oct 2025▲Q3 2025 results beat the low bar as cost savings, working capital improvement, and new growth investments helped results. Management still guided Q4 EBITDA to about $725 million, showing the recovery was not secure.

Jul 2025→Dow delayed its Path2Zero project and cut expected 2025 capital spending by $1 billion, which helped preserve cash. The same update showed how serious the downturn had become, including more European asset actions.

Jul 2025▼Management cut the dividend by 50% and adopted a lower-for-longer industry view. The cut improved financial flexibility, but it confirmed a deeper earnings trough.

02 Business model

Scale chemicals, thin cycle margins

Dow sells chemical materials to other businesses. Its products go into food packaging, pipes, insulation, cars, coatings, electronics, home care, and many other end markets. Customers buy tons of material, so small price changes can move profit a lot.

The company makes many products from hydrocarbons and other feedstocks, which are raw materials used to make chemicals. Dow benefits when its input costs are low, its plants run at high rates, and global supply is tight. It gets hurt when competitors add too much capacity or when customers slow orders.

Packaging & Specialty Plastics is the largest segment and is central to the current upside case. Dow can gain when polyethylene prices rise and integrated margins expand, meaning the spread between selling prices and input costs improves.

Management is trying to make the business less exposed to the next downcycle. Transform to Outperform is meant to simplify the operating model, cut costs, and fund faster growth. The plan also has real costs, including $1.1 billion to $1.5 billion of cash costs and a workforce reduction of about 4,500 roles.

03 Product portfolio

What Dow sells

Cash cow

Polyethylene and specialty plastics

These materials are used in packaging, transportation, and infrastructure. This is the main area where tight supply and better pricing could lift earnings.

Steady

Hydrocarbons and energy

This part supports Dow's large chemical production system. Its value depends on plant uptime, feedstock costs, and energy spreads.

Option

Polyurethanes and construction chemicals

These products serve construction, automotive, and industrial markets. The business has been under pressure, and Dow recorded a $690 million impairment tied to this reporting unit in 2025.

Steady

Industrial solutions

These chemicals go into industrial applications where demand often follows factory activity and global GDP. Lower raw material costs can help, but weak selling prices still hurt.

Steady

Consumer silicones

Dow sells downstream silicones into home care, personal care, and electronics. This gives the portfolio some exposure beyond basic plastics.

Steady

Coatings and performance monomers

These products go into industrial and architectural coatings, plastic additives, and related uses. In Q1 2026, the broader Performance Materials & Coatings segment was the only segment not to report lower sales year over year.

04 Business segments

Q1 sales mix

Packaging & Specialty Plastics51%declining

Industrial Intermediates & Infrastructure27%declining

Performance Materials & Coatings22%flat

The segment mix uses Q1 2026 segment net sales: $4.92 billion for Packaging & Specialty Plastics, $2.63 billion for Industrial Intermediates & Infrastructure, and $2.08 billion for Performance Materials & Coatings. Shares are normalized to those three segment figures, not total company net sales.

05 Risk factors

What could break the thesis

Supply shock fades too soon

High impact · Medium odds

Management's Q2 guide depends in part on pricing gains and expanding margins after the Middle East conflict disrupted supply chains. If the conflict eases or shipping and feedstock flows normalize faster than the 275 day estimate, chemical prices could drop quickly. That would test how much of the earnings lift is real self-help versus a temporary market squeeze.

We watchPolyethylene price increases, integrated margins, and management's Q3 pricing comments.

Cost plan misses its target

High impact · Medium odds

Transform to Outperform targets at least $2 billion of near-term EBITDA improvement. About two-thirds is expected from productivity gains and the rest from growth. The first site transformation found about $80 million of run-rate EBITDA improvement, but future sites may not repeat that result.

We watchReported progress toward the $400 million savings target for the second half of 2026 and updates on site transformation savings.

Another chemical downcycle

High impact · Medium odds

Dow's 2025 Form 10-K said slower global GDP growth, weak market conditions, and industry overcapacity hurt results and were expected to persist near term. If demand weakens again before the cost cuts land, Dow could be caught with lower prices, weaker volumes, and restructuring cash costs at the same time.

We watchQuarterly local price, volume, plant utilization, and order book trends.

Balance sheet pressure

Medium impact · Medium odds

In February 2026, S&P lowered TDCC's long-term credit rating to BBB- and Moody's lowered it to Baa3, both with negative outlooks. Those ratings are still investment grade, but they leave less room for mistakes. Higher borrowing costs or tighter access to credit would reduce flexibility during a downturn.

We watchAny further S&P or Moody's action, free cash flow, and debt reduction progress.

Restructuring disrupts operations

Medium impact · Medium odds

Dow plans to cut about 4,500 roles and spend $1.1 billion to $1.5 billion in cash costs on the restructuring. Big cuts can lower costs, but they can also slow service, weaken plant execution, or hurt morale. The risk rises if the company pushes changes while markets stay volatile.

We watchCustomer service metrics, plant outage commentary, restructuring charges, and employee reduction timing.

06 Quick answers

In one breath

Why did Dow's outlook improve in 2026?

Management said the Middle East conflict caused a sharp positive inflection in March orders and expects the supply disruption to last through 2026. That can raise prices and margins, especially in plastics.

What is Transform to Outperform?

It is Dow's 2026 restructuring program. The plan targets at least $2 billion of near-term EBITDA improvement through productivity gains and growth, while cutting about 4,500 roles.

Is Dow a growth stock?

Not in the usual sense. Dow is a cyclical materials company, so earnings often move with chemical prices, raw material costs, and global demand.

What should investors watch next?

The main test is Q2 delivery. Management guided to about $12 billion of revenue and $2 billion of EBITDA, so that report will show whether the pricing tailwind is as strong as promised.